FDA Approves KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in ... - MarketWatch (press release)

TopNews United Kingdom (blog)

FDA Approves KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in ... MarketWatch (press release) ... who suffer with chronic gout that is refractory to conventional therapy based on the KRYSTEXXA comprehensive and current benefit:risk information. ... Savient Pharma Balances Launching Drug, Selling SelfWall Street Journal Savient receives FDA approval for gout drugExaminer.com Savient Gout Drug Wins FDA OK; Firm for SaleBioWorld Online DrugWatch.com -BioMedReports (subscription) -WebMD all 199 news articles »

Q Nutrition: Arthritis is not always to blame for aches and pains - San Diego Gay & Lesbian News

San Diego Gay & Lesbian News

Q Nutrition: Arthritis is not always to blame for aches and pains San Diego Gay & Lesbian News These are some things to consider when arthritis symptoms occur – Nightshade foods, Artificial sweeteners, MSG, stevia, Prescription drugs, Gout, Hormones, ...

Ouch! It's gout - Malaysia Star

Ouch! It's gout Malaysia Star The information contained in this column is for general educational purposes only. Neither The Star nor the author gives any warranty on accuracy, ...

FDA Calls for Halt on Marketing of Unapproved Colchicine Orders companies to ... - ModernMedicine

MD News (press release)

FDA Calls for Halt on Marketing of Unapproved Colchicine Orders companies to ... ModernMedicine Colchicine is commonly used to prevent and treat gout and to treat familial Mediterranean fever. Although many single-ingredient oral colchicine products ... FDA: Stop marketing unapproved colchicineAmerican Pharmacists Association, pharmacist.com all 39 news articles »